Search results - ORA - Oxford University Research Archive

« Previous | 1 - 20 of 76 | Next »

1

Conference item

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes

Wilson, J, Dutton, S, Hackett, S, et al.
2017-01-31

2

Conference item

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer

Holyoake, D, Wilson, J, Partridge, M, et al.
2016-08-21

3

Journal article

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy

Wilson, J, Mukherjee, S, Brunner, T, et al.
2017-02-01

4

Journal article

Targeting ATR in DNA damage response and cancer therapeutics.

Fokas, E, Prevo, R, Hammond, E, et al.
2014-02-01

5

Journal article

Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma.

Mantoni, T, Schendel, R, Rödel, F, et al.
2008-11-01

6

Journal article

The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.

Prevo, R, Fokas, E, Reaper, P, et al.
2012-09-01

7

Journal article

Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.

Fokas, E, Prevo, R, Pollard, J, et al.
2012-01-01

8

Journal article

Cancer stem cells as a predictive factor in radiotherapy.

Brunner, T, Kunz-Schughart, L, Grosse-Gehling, P, et al.
2012-04-01

9

Journal article

Quality of training in radiation oncology in Germany. Results of a 2006 survey.

Semrau, R, Hansemann, K, Adam, M, et al.
2008-05-01

10

Conference item

A phase I trial of the farnesyltransferase and geranylgeranyltransferase-I inhibitor L-778,123 (L-778) and radiotherapy for locally advanced pancreatic cancer.

Martin, N, Brunner, T, Bernhard, E, et al.
2004-07-15

11

Conference item

Radioresistance of cancer stem cells

Brunner, T, Al-Assar, O, Muschel, R, et al.
2009-09-01

12

Journal article

Comparison of four target volume definitions for pancreatic cancer. Guidelines for treatment of the lymphatics and the primary tumor.

Fokas, E, Eccles, C, Patel, N, et al.
2013-05-01

13

Journal article

Targeting ATR in DNA damage response and cancer therapeutics

Fokas, E, Prevo, R, Hammond, E, et al.
2014-01-01

14

Journal article

Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers.

Al-Assar, O, Muschel, R, Mantoni, T, et al.
2009-11-01

15

Journal article

Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma

Mantoni, T, Schendel, R, Rödel, F, et al.
2008-11-01

16

Journal article

Farnesyltransferase inhibitors as radiation sensitizers.

Brunner, T, Gupta, A, Shi, Y, et al.
2003-07-01

17

Conference item

PREOPERATIVE CHEMORADIATION FOR RESECTABLE ADENOCARCINOMA OF THE PANCREAS (ISRCTN 78805636): PATTERN OF RECURRENCE.

Golcher, H, Witzigmann, H, Marti, L, et al.
2012-06-01

18

Conference item

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer

Brunner, T, Geiger, M, Grabenbauer, G, et al.
2008-05-01

19

Conference item

Predicting Respiratory Motion for Patients Undergoing Pancreatic Chemoradiation in the Absence of Volumetric Motion Imaging

Eccles, C, Scott-Brown, M, McKenna, W, et al.
2010-01-01

20

Journal article

Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.

Brunner, T, Rupp, A, Melzner, W, et al.
2008-01-01

TO TOP